Albireo Pharma, Inc.
USD44.15
+0.00 (+0.00%)
CEO
Ronald H. W. Cooper
IPO Date
2007-05-11
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$44.90
Prev. Close
$44.15
Day Low
$44.00
Day High
$44.90
52W Low
$16.02
52W High
$45.23
Market Cap
$0.92B
Volume
1.24M
| -5.0 |
| 31 Dec 2019 | FY | 77.1% | -744.1% | -77.0% | -43.4% | 0.00 | 7.49 | -4.4 |
| 31 Dec 2018 | FY | 100.0% | -361.9% | -37.6% | -24.9% | 0.00 | 13.07 | -6.2 |
| 31 Dec 2017 | FY | 100.0% | -2441400.0% | -37.4% | -33.3% | 0.00 | 6.94 | -8.2 |
| 31 Dec 2016 | FY | 100.0% | -143.9% | -44.2% | -32.9% | 0.08 | 2.43 | -1.3 |
| 30 Sept 2015 | FY | 0.0% | 0.0% | -47.4% | -45.2% | 0.00 | 22.74 | -1.1 |
| 30 Sept 2014 | FY | 0.0% | 0.0% | -62.0% | -55.6% | 0.00 | 15.41 | -0.7 |
| 30 Sept 2013 | FY | 0.0% | 0.0% | -59.4% | -47.0% | 0.00 | 16.42 | -0.4 |
| 30 Sept 2012 | FY | 0.0% | 0.0% | -66.9% | -50.4% | 0.00 | 14.22 | -0.3 |
| -2.3 |
| 31 Mar 2022 | Q1 | 96.6% | -663.2% | -30.6% | -17.3% | 0.07 | 7.26 | -3.2 |
| 31 Dec 2021 | Q4 | 97.2% | -33.7% | -6.2% | -3.6% | 0.06 | 5.93 | -10.2 |
| 30 Sept 2021 | Q3 | 88.2% | 1558.0% | 31.4% | 19.3% | 0.05 | 8.20 | 2.6 |
| 30 Jun 2021 | Q2 | 100.0% | -1500.0% | -32.1% | -16.6% | 0.09 | 7.23 | -4.6 |
| 31 Mar 2021 | Q1 | 100.0% | -2224.5% | -29.6% | -17.5% | 0.07 | 10.17 | -3.9 |
| 31 Dec 2020 | Q4 | 100.0% | -913.1% | -13.7% | -8.7% | 0.05 | 10.36 | -7.2 |
| 30 Sept 2020 | Q3 | 100.0% | -1442.7% | -14.5% | -9.9% | 0.04 | 13.51 | -4.3 |
| 30 Jun 2020 | Q2 | 100.0% | -1077.6% | -23.1% | -11.2% | 0.11 | 9.29 | -4.8 |